Dipeptidyl Peptidase-4 Inhibition and Immune Function in HIV (DPPIVinHIV)

This study has been completed.
Sponsor:
Collaborator:
The Campbell Foundation
Information provided by (Responsible Party):
Kevin Yarasheski, PhD, Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT01093651
First received: March 23, 2010
Last updated: June 22, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2012
  Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)